ADVISORY RESEARCH INC - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
ADVISORY RESEARCH INC ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$1,311,825
-10.6%
25,276
+3.3%
0.18%
-3.2%
Q2 2023$1,466,862
+45.5%
24,464
+20.0%
0.19%
+13.3%
Q1 2023$1,008,131
-17.5%
20,391
-4.7%
0.17%
+44.3%
Q4 2022$1,221,356
-4.2%
21,401
-21.2%
0.12%
-8.0%
Q3 2022$1,275,00027,1710.12%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$28,523,07325.19%
Velan Capital Investment Management LP 200,000$9,888,0008.43%
RTW INVESTMENTS, LP 5,649,943$279,333,1825.82%
Paradigm Biocapital Advisors LP 1,126,256$55,682,0975.28%
Rock Springs Capital Management LP 3,001,662$148,402,1693.54%
Logos Global Management LP 500,000$24,720,0003.54%
TANG CAPITAL MANAGEMENT LLC 405,600$20,052,8642.99%
GREAT POINT PARTNERS LLC 255,367$12,625,3442.48%
COWEN AND COMPANY, LLC 405,174$20,031,8022.35%
Eschler Asset Management LLP 60,000$2,966,4002.34%
View complete list of IMMUNOCORE HLDGS PLC shareholders